GRANIX
These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012
df918ec2-0907-443f-a52a-b72866959644
HUMAN PRESCRIPTION DRUG LABEL
Nov 30, 2023
Cephalon, LLC
DUNS: 183236314
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
tbo-filgrastim
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
tbo-filgrastim
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
tbo-filgrastim
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
tbo-filgrastim
Product Details
FDA regulatory identification and product classification information